Zhejiang Hengkang Deferasirox Zhejiang Hengkang Deferasirox

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Deferasirox

    Client Email Product

    Deferasirox

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    68
    US DMFs Filed

    US DMFs Filed

    23
    CEP/COS Certifications

    CEP/COS Certifications

    10
    JDMFs Filed

    JDMFs Filed

    1
    Other Certificates

    Other Certificates

    23
    Other Suppliers

    Other Suppliers

    49
    API REF. PRICE (USD / KG)
    421

    API Market Place

    10
    INTERMEDIATES
    25
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    101
    Europe

    Europe

    4
    Canada

    Canada

    24
    Australia

    Australia

    144
    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    34
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    1,479.00

    Annual Reports

    1,099.00

    FDF Market Place

    3
    EXCIPIENTS
    83
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    3

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    3

    News

    56
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    13
    SERVICES

    0

    left grey arrow
    right gray arrow
    • GRANULE;ORAL - 180MG
    • GRANULE;ORAL - 360MG
    • GRANULE;ORAL - 90MG
    Full View ScreenFull Screen View
    Enforcement Report - Week of November 15, 2023
    Enforcement Report - Week of November 15, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-15-2023-17266.pdf

    FDA
    15 Nov 2023
    Share Share
    Teva's Generic Deferasirox Receives Approval in the U.S.
    Teva's Generic Deferasirox Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207124

    FDA
    23 Sep 2022
    Share Share
    Annora's Generic Deferasirox Receives Approval in the U.S.
    Annora's Generic Deferasirox Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216229

    FDA
    22 Sep 2022
    Share Share
    Teva Pharma's Generic Deferasirox Receives Approval in the US
    Teva Pharma's Generic Deferasirox Receives Approval in the US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214180

    FDA
    19 Nov 2021
    Share Share
    Celltrion`s Generics Deferasirox Receives Approval in US
    Celltrion`s Generics Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212669

    FDA
    30 May 2021
    Share Share
    Annora Pharma`s Generic Deferasirox Receives Approval In US
    Annora Pharma`s Generic Deferasirox Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214341

    FDA
    18 May 2021
    Share Share
    MSN`s Generic Deferasirox Receives Approval In US
    MSN`s Generic Deferasirox Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214650

    FDA
    23 Mar 2021
    Share Share
    Alkem Lab Generic Deferasirox Receives Approval in US
    Alkem Lab Generic Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213374

    FDA
    18 Jul 2020
    Share Share
    Alkem Lab Generic Deferasirox Receives Approval in US
    Alkem Lab Generic Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210555

    FDA
    08 Jul 2020
    Share Share
    MSN `s Generic Deferasirox Receives Tentative Approval In US
    MSN `s Generic Deferasirox Receives Tentative Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210945

    FDA
    23 Jun 2020
    Share Share
    Piramal Healthcare`s Generic Deferasirox Receives Approval in U.S
    Piramal Healthcare`s Generic Deferasirox Receives Approval in U.S

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212995

    FDA
    23 Jun 2020
    Share Share
    Cipla`s Generic Albuterol Sulfate Receive Approval in US
    Cipla`s Generic Albuterol Sulfate Receive Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211852

    FDA
    23 Jun 2020
    Share Share
    Alembic Pharma`s Generic Deferasirox Receives Approval in U.S
    Alembic Pharma`s Generic Deferasirox Receives Approval in U.S

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211824

    FDA
    22 Jun 2020
    Share Share
    Sun Pharm`s Generic Deferasirox Receives Approval In Us
    Sun Pharm`s Generic Deferasirox Receives Approval In Us

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211641

    FDA
    22 Jun 2020
    Share Share
    Zydus Pharms`s Generic Deferasirox Receives Approval in US
    Zydus Pharms`s Generic Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211383

    FDA
    22 Jun 2020
    Share Share
    Amneal Pharmaceuticals Generic Deferasirox Receives Approval in US
    Amneal Pharmaceuticals Generic Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210727

    FDA
    22 Jun 2020
    Share Share
    Zydus Cadila gets USFDA approval to market generic version of Deferasirox
    Zydus Cadila gets USFDA approval to market generic version of Deferasirox

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-approval-to-market-generic-version-of-deferasirox-tablets/articleshow/76399918.cms

    INDIATIMES
    16 Jun 2020
    Share Share
    Zydus receives USFDA final approval for Deferasirox Tablets
    Zydus receives USFDA final approval for Deferasirox Tablets

    https://www.business-standard.com/article/news-cm/zydus-receives-usfda-final-approval-for-deferasirox-tablets-120061600422_1.html

    BUSINESS
    15 Jun 2020
    Share Share
    Alembic Pharma gets US FDA approval for generic Jadenu tablets
    Alembic Pharma gets US FDA approval for generic Jadenu tablets

    http://www.pharmabiz.com/NewsDetails.aspx?aid=128872&sid=2

    PHARMABIZ
    15 Jun 2020
    Share Share
    Alembic Pharma hits 52-week high on final USFDA approval for Deferasirox tablets
    Alembic Pharma hits 52-week high on final USFDA approval for Deferasirox tablets

    https://www.moneycontrol.com/news/business/stocks/alembic-pharma-hits-52-week-high-on-final-usfda-approval-for-deferasirox-tablets-5410731.html

    MONEYCONTROL
    15 Jun 2020
    Share Share
    Cipla's Generic Deferasirox Receive Approval in U.S
    Cipla's Generic Deferasirox Receive Approval in U.S

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211852

    FDA
    15 Feb 2020
    Share Share
    Glenmark gets US FDA nod for tablet used to treat high levels of iron
    Glenmark gets US FDA nod for tablet used to treat high levels of iron

    https://www.business-standard.com/article/pti-stories/glenmark-gets-usfda-s-final-nod-for-deferasirox-tablets-120010700282_1.html

    BUSINESS STANDARD
    08 Jan 2020
    Share Share
    Glenmark gets US FDA nod for tablet used to treat high levels of iron
    Glenmark gets US FDA nod for tablet used to treat high levels of iron

    https://www.business-standard.com/article/pti-stories/glenmark-gets-usfda-s-final-nod-for-deferasirox-tablets-120010700282_1.html

    BUSINESS STANDARD
    08 Jan 2020
    Share Share
    Glenmark gets US FDA nod for tablet used to treat high levels of iron
    Glenmark gets US FDA nod for tablet used to treat high levels of iron

    https://www.business-standard.com/article/pti-stories/glenmark-gets-usfda-s-final-nod-for-deferasirox-tablets-120010700282_1.html

    BUSINESS STANDARD
    07 Jan 2020
    Share Share
    Glenmark Pharm's Generic Deferasirox Receives Approval In Us
    Glenmark Pharm's Generic Deferasirox Receives Approval In Us

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209433

    FDA
    03 Jan 2020
    Share Share
    Sun Pharm's Generic Deferasirox Receives Approval In Us
    Sun Pharm's Generic Deferasirox Receives Approval In Us

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211641

    FDA
    01 Jan 2020
    Share Share
    Amneal Pharmaceutical`s Generic Deferasirox Receives Approval in US
    Amneal Pharmaceutical`s Generic Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210727

    FDA
    27 Dec 2019
    Share Share
    Actavis Elizabeth’s Generic Deferasirox Receives Approval In US
    Actavis Elizabeth’s Generic Deferasirox Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208697

    FDA
    17 Dec 2019
    Share Share
    Dr Reddy's launches chronic iron overload treatment tablets in US
    Dr Reddy's launches chronic iron overload treatment tablets in US

    https://www.moneycontrol.com/news/business/dr-reddys-launches-chronic-iron-overload-treatment-tablets-in-us-4705981.html

    MONEY CONTROL
    10 Dec 2019
    Share Share
    Dr. Reddy's Launches Deferasirox Tablets for Oral Suspension in the U.S.
    Dr. Reddy's Launches Deferasirox Tablets for Oral Suspension in the U.S.

    https://www.businesswire.com/news/home/20191206005100/en

    BUSINESS WIRE
    06 Dec 2019
    Share Share
    Alembic Pharmaceuticals's Generic Deferasirox Receives Approval in U.S
    Alembic Pharmaceuticals's Generic Deferasirox Receives Approval in U.S

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211824

    FDA
    26 Nov 2019
    Share Share
    Alembic Pharma gets USFDA nod for generic iron overload treatment tablets
    Alembic Pharma gets USFDA nod for generic iron overload treatment tablets

    https://www.moneycontrol.com/news/business/alembic-pharma-gets-usfda-nod-for-generic-chronic-iron-overload-treatment-tablets-4665121.html

    MONEY CONTROL
    23 Nov 2019
    Share Share
    Cadila Healthcare's Generic Deferasirox Receives Approval in US
    Cadila Healthcare's Generic Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211383

    FDA
    22 Nov 2019
    Share Share
    Alembic Pharmaceutical's Generic Deferasirox Receives Approval in US
    Alembic Pharmaceutical's Generic Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211824

    FDA
    21 Nov 2019
    Share Share
    MSN Laboratorie's Generic Deferasirox Receives Approval in US
    MSN Laboratorie's Generic Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210945

    FDA
    21 Nov 2019
    Share Share
    MSN Laboratorie's Generic Deferasirox Receives Approval in US
    MSN Laboratorie's Generic Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210945

    FDA
    21 Nov 2019
    Share Share
    Bionpharma's Generic Deferasirox Receives Approval in US
    Bionpharma's Generic Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210920

    FDA
    21 Nov 2019
    Share Share
    Alkem's Generic Deferasirox Receives Approval in US
    Alkem's Generic Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210519

    FDA
    21 Nov 2019
    Share Share
    Alembic Pharmaceuticals Generic Deferasirox Receives Approval in US
    Alembic Pharmaceuticals Generic Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210060

    FDA
    21 Nov 2019
    Share Share
    MSN Laboratorie's Generic Deferasirox Receives Approval in US
    MSN Laboratorie's Generic Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209878

    FDA
    21 Nov 2019
    Share Share
    Sun Pharma's Generic Deferasirox Receives Approval in US
    Sun Pharma's Generic Deferasirox Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209782

    FDA
    21 Nov 2019
    Share Share
    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics

    https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic

    Angus Liu FIERCE PHARMA
    21 Jun 2019
    Share Share
    Teva announces launch of generic version of EXJADE®
    Teva announces launch of generic version of EXJADE®

    https://www.biospectrumasia.com/news/33/13099/teva-announces-launch-of-generic-version-of-exjade-.html

    BIOSPECTRUMASIA
    25 Mar 2019
    Share Share
    Teva Announces Launch of a Generic EXJADE (deferasirox) Tablets
    Teva Announces Launch of a Generic EXJADE (deferasirox) Tablets

    https://www.businesswire.com/news/home/20190322005444/en

    BUSINESSWIRE
    22 Mar 2019
    Share Share
    Zydus Pharms ' Generic Deferasirox Receives Tentative Approval in US
    Zydus Pharms ' Generic Deferasirox Receives Tentative Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211383

    FDA
    23 Nov 2018
    Share Share
    Zydus receives US FDA tentative approval to market Exjade tablets
    Zydus receives US FDA tentative approval to market Exjade tablets

    http://www.pharmabiz.com/NewsDetails.aspx?aid=112401&sid=2

    PHARMABIZ
    20 Nov 2018
    Share Share
    List of centrally authorised products requiring a notification of a change for update of annexes
    List of centrally authorised products requiring a notification of a change for update of annexes

    https://www.ema.europa.eu/documents/regulatory-procedural-guideline/list-centrally-authorised-products-requiring-notification-change-update-annexes_en-0.pdf

    EMA
    12 Oct 2018
    Share Share
    Bionpharma's Generic Deferasirox Receives Tentative Approval in US
    Bionpharma's Generic Deferasirox Receives Tentative Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210920

    FDA
    06 Sep 2018
    Share Share
    Zydus Pharms USA Inc.’s Generic Deferasirox Receives Tentative Approval in the US
    Zydus Pharms USA Inc.’s Generic Deferasirox Receives Tentative Approval in the US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208882

    FDA
    09 Jul 2018
    Share Share
    FDA Confirms Paragraph IV Patent Challenge of Jadenu (Deferasirox) Tablets
    FDA Confirms Paragraph IV Patent Challenge of Jadenu (Deferasirox) Tablets

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-jadenu-deferasirox-tablets-1506579105.pdf

    FDA
    27 Sep 2017
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Synnat Deferasirox

    Access Virtual Booth

    Contact Supplier

    View Presentation

    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search